In a series of special reports, Drug Store News looks at some of the top trends impacting pharmacy in this pivotal year for the nation’s health system.
The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.
CVS Health's chief medical officer is addressing the National Business Group on Health.
McKesson Care Management has been recognized for its processes, quality program and reporting, and care management electronic capture system.
CHPA announced its strong support for the Restoring Access to Medicines Act of 2015 (H.R. 1270).
The brand's latest survey was designed to help understand the impact of the common cold and/or flu at the individual level.
Pharmacy Quality Alliance and AllazoHealth announced the formation of a formal research partnership to study and improve medication adherence metrics.
Researchers have assessed the relationship between changes in a person’s activation level and changes in health outcomes and cost.
Healthcare systems should increasingly focus on digital technology as tech-savvy seniors seek more online options to access healthcare services from their home, according to a recent survey.
The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.